Prophylactic Surfactant by Thin Endotracheal Catheter for Preterm Infants At Birth: the ProTeCt Trial
Recruiting
N/A
Interventional Study
Infant, Newborn, Diseases
Prematurity
Prematurity; Extreme
Respiratory Distress Syndrome in Premature Infant
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- Up to 30 Minutes
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 164 (estimated)
- Sponsor
- University College Dublin · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn whether giving surfactant through a thin endotracheal catheter to extremely premature babies shortly after birth reduces the number of them who are ventilated in the first 3 days of life.
The main question it aims to answer is:
Do fewer babies who receive prophylactic thin catheter surfactant under video laryngoscopy shortly after birth go on to be ven…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria
* Infants of any sex born before 28 weeks of gestation
* Clinicians plan to provide intensive care
* Consent for their participation provided by parent(s)/guardian(s) before their birth
Exclusion criteria
• Major congenital anomalies (e.g. upper airway anomaly, diaphragmatic he…
Contacts